Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SnRNAseq of mouse kidney from proximal tubule ACE KO mice

ABSTRACT: ACE2, a membrane-bound monocarboxypeptidase with high affinity for angiotensin II (AngII), is highly expressed in the renal proximal tubule (PT). Previously, we reported elevated renal AngII levels associated with enhanced hypertension in mice globally lacking ACE2 and a role for soluble ACE2 in hypertension. Using a new mouse model, we now test the hypothesis that the PT of the kidney is a critical site for ACE2 in BP regulation acting via the intra-renal renin angiotensin system. Mice with specific deletion of ACE2 from the PT (PT ACE2 KO) have an exaggerated, initial BP response to AngII infusion, sufficient to cause cardiac hypertrophy. During this early period, reductions in key sodium transporters are observed in PT ACE2 KO mice in contrast to control mice, which instead increase renal ACE2 expression and urinary ACE2 excretion to reduce renal AngII accumulation. Quantitative molecular profiling of sodium transporters reflects impact of ACE2 deletion on homeostasis and offers mechanisms underlying AngII hypertension. Loss of ACE2 from the renal PT is sufficient to cause an exaggerated BP response and concomitant alterations in sodium reabsorption along the entire nephron. These studies reveal a dynamic pattern of intra-renal RAS regulation aimed at mitigating hypertension.

ORGANISM(S): Mus musculus

PROVIDER: GSE253448 | GEO | 2026/06/04

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-seq analysis of mouse aortic endothelial cells of angiotensin II hypertensive mice

Project description:To explore the role of endothelial cells in hypertension, we developed an angiotensin II-induced mouse hypertension model. Eight-week-old C57BL/6 mice were anesthetized using 2% pentobarbital sodium, and osmotic pumps were subcutaneously implanted to deliver AngII at a constant rate of 1000 ng/kg/min over 14 consecutive days. Sham-operated mice underwent the identical procedure, with osmotic pumps containing 0.9% saline implanted subcutaneously instead. Subsequently, mouse aortic endothelial cells were isolated and subjected to RNA sequencing analysis.

2026-01-01 | GSE304402 | GEO

Gene expression profiling using microarray in rat aortic vascular smooth muscle cells in response to Angiotensin II stimulation

Project description:Increased level of the hormone angiotensin II (AngII) contributes to the development of several cardiovascular issues, including atherosclerosis, vascular remodeling, and hypertension by altering gene expression. In our study, we use microarray analysis to investigate the effect of AngII on primary vascular smooth muscle cells derived from rat thoracic aorta. We have identified genes upregulated in response to AngII and are investigating their contribution to these cardiovascular conditions.

2024-11-28 | E-MTAB-14626 | biostudies-arrayexpress

RAAS-Deficient Organoids Reveal that Delayed Angiogenesis Is The Pathomechanism Underlying Autosomal Recessive Renal Tubular Dysplasia

Project description:Autosomal Recessive Renal Tubular Dysgenesis (AR-RTD) is a fatal genetic disorder affecting proximal tubule (PT) development in patients harboring mutations in genes comprising the Renin–Angiotensin–Aldosterone System (RAAS). To uncover the pathomechanism of AR-RTD, we differentiated ACE and AGTR1 deficient pluripotent stem cells and reprogrammed AR-RTD patient cells into kidney organoids. Marker analyses confirmed that all mutant and control organoids generated PT in room air (21% O2) or under hypoxic conditions (2% O2). Mature (d24) AGTR1-/- and control organoids transplanted under the kidney capsule of immunodeficient mice engrafted and differentiated well, as did renal vesicle stage (d14) control organoids. By contrast, d14 AGTR1-/- organoids failed to engraft due to insufficient pro-angiogenic VEGF-A expression. When grown under hypoxic conditions VEGF-A expression was stimulated and organoids engrafted. Thus, PT dysgenesis in AR-RTD is a non-autonomous consequence of a developmental delay in VEGF-A induction linking ANGII pro angiogenic role to PT dysgenesis.

2023-10-18 | GSE229842 | GEO

Transcriptome profiling of vascular tissues in Angiotensin II-dependent hypertension in vivo

Project description:We hypothesized that angiotensin II (AngII) affects transcriptome in the vasculature in a region-specific manner, which may help to identify genes causally related to the development of AngII-induced hypertension. This work was supported by the National Science Centre grant (decision no. DEC-2012/07/D/NZ4/00644).

2017-02-20 | GSE75815 | GEO

Protective mechanisms of Qingda granule in hypertensive kidney injury: Focus on ERK/RSK1-mediated mitochondrial protection

Project description:The objective of this study was to compare blank control mice (WT) with AngII-induced hypertensive mice (M). Angii-induced hypertensive mice (M) and QDG intervention group (QDG); Different genes expressed in renal tissue and identify new targets for reversing hypertension-induced renal damage.

2024-11-12 | GSE281114 | GEO

2008-02-28 | GSE10648 | GEO

Qingda granule（QDG） treatment lower Angiotensin-II-induced blood pressure

Project description:The goals of this study is to compare the differently expressed genes in renal tissue of C57BL/6 WT mice with or without Angiotensin II (AngII) treatment as well as differently expressed genes in the renal tissue of WT mice with AngII treatment with or without Qingda granule（QDG）treatment. The mice (n=15) were randomly divided into 3 groups: control, AngII,AngII+ QDG (n=5 for each group). Mice in Control and AngII groups were infused with saline or 500 ng/kg/min of AngII respectively, and intragastrically with double distilled water (dd H2O); while mice in AngII + QDG groups were infused with AngII (500 ng/kg/min) and intragastrically with 1.145 g/kg/D of QDG for 4 weeks. Then the renal tissue were used to identify differentially expressed genes among different groups.

2022-03-02 | GSE182517 | GEO

Quercetin treatment lower Angiotensin-II-induced blood pressure

Project description:The goals of this study is to compare the differently expressed genes in renal tissue of C57BL/6 WT mice with or without Angiotensin II (AngII) treatment as well as differently expressed genes in the renal tissue of WT mice with AngII treatment with or without Quercetin (Que) treatment. The mice (n=18) were randomly divided into 3 groups: control, AngII,AngII+ Que (n=6 for each group). Mice in Control and AngII groups were infused with saline or 500 ng/kg/min of AngII respectively, and intragastrically with double distilled water (dd H2O); while mice in AngII + Que groups were infused with AngII (500 ng/kg/min) and intragastrically with 5mg/kg/D of Que for 4 weeks. Then the renal tissue were used to identify differentially expressed genes among different groups.

2022-07-15 | GSE207102 | GEO

Project description:Proteinuria is pathogenic to proximal tubular cells (PTC) and linked with progression to renal failure. Angiotensin II (AngII) is also independently involved in the pathogenesis of progressive renal injury in varied kidney disease. The effects of human serum albumin (HSA) overload, AngII and candesartan, a specific inhibitor of AngII type 1 recptor, on the changes in gene protein expression stimulated by oxidative stress in PTC were assesed using cDNA microarrays. Keywords: stress response Cells were growth arrested for 48 h in serum-free DMEM/Ham's F-12 medium with 5.5 mM glucose, 2 mM L-glutamine,100 U/ml penicillin, 100 ug/ml streptomycin, 20 mM Hepes. Media were refreshed and cells were incubated for 24h in conditioned media alone, or with media supplemented with 30mg/ml of different HSA preparations, 1 uM AngII or AngII in the presence of candesartan. After further 24 h under standard cell culture conditions (37C, 5% CO2) cells were subjected to RNA extraction.

2010-06-25 | E-GEOD-10648 | biostudies-arrayexpress

Effects of potassium supplementation and depletion in the development of salt-sensitive hypertension in male and female rats

Project description:The inverse effects that dietary sodium and potassium have on blood pressure have been known for some time. High sodium consumption is detrimental, while potassium supplementation is known to be beneficial, and the ratio of sodium/potassium consumption is also very important to consider when determining how these electrolytes affect salt-induced hypertension; however, the mechanisms behind the beneficial effects of potassium are still not yet entirely established. Inwardly rectifying potassium (Kir) channels have been shown to play a major role in potassium transport and homeostasis in the kidney and might contribute to these effects. Here we aimed to examine how different variations in the sodium/potassium ratio affect the development of salt-sensitive hypertension and how channels and transporters in the kidney are altered to accommodate these changes. We hypothesize that these diets will affect the development of salt-sensitive hypertension, and that Kir channels will play a major role in the renal adaptations to varying intakes of potassium

2024-02-24 | GSE255582 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data